09:45 AM EST - Medicago Inc. : and Cellectis Plant Sciences, a subsidiary of Cellectis SA, the French specialist in genome engineering, today announced the signing of a research agreement under which Medicago and Cellectis will collaborate to improve therapeutic proteins expressed from tobacco leaves. Medicago Inc.
shares T.MDG are trading even at $0.63.
